NM_006073.4:c.277C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_006073.4(TRDN):​c.277C>T​(p.Arg93Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000117 in 1,554,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R93S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000070 ( 0 hom. )

Consequence

TRDN
NM_006073.4 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 1.89

Publications

5 publications found
Variant links:
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
TRDN Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • familial long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010916054).
BP6
Variant 6-123548568-G-A is Benign according to our data. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187. Variant chr6-123548568-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 415187.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000552 (83/150464) while in subpopulation AFR AF = 0.00193 (79/40928). AF 95% confidence interval is 0.00159. There are 0 homozygotes in GnomAd4. There are 40 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRDNNM_006073.4 linkc.277C>T p.Arg93Cys missense_variant Exon 3 of 41 ENST00000334268.9 NP_006064.2 Q13061-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRDNENST00000334268.9 linkc.277C>T p.Arg93Cys missense_variant Exon 3 of 41 1 NM_006073.4 ENSP00000333984.5 Q13061-1

Frequencies

GnomAD3 genomes
AF:
0.000552
AC:
83
AN:
150352
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00194
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000664
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.000966
GnomAD2 exomes
AF:
0.000187
AC:
35
AN:
186764
AF XY:
0.000169
show subpopulations
Gnomad AFR exome
AF:
0.00244
Gnomad AMR exome
AF:
0.000119
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000705
AC:
99
AN:
1404404
Hom.:
0
Cov.:
35
AF XY:
0.0000619
AC XY:
43
AN XY:
695198
show subpopulations
African (AFR)
AF:
0.00176
AC:
56
AN:
31784
American (AMR)
AF:
0.0000800
AC:
3
AN:
37490
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24874
East Asian (EAS)
AF:
0.0000533
AC:
2
AN:
37490
South Asian (SAS)
AF:
0.0000782
AC:
6
AN:
76746
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50898
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5634
European-Non Finnish (NFE)
AF:
0.0000259
AC:
28
AN:
1081544
Other (OTH)
AF:
0.0000518
AC:
3
AN:
57944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000552
AC:
83
AN:
150464
Hom.:
0
Cov.:
31
AF XY:
0.000546
AC XY:
40
AN XY:
73292
show subpopulations
African (AFR)
AF:
0.00193
AC:
79
AN:
40928
American (AMR)
AF:
0.0000663
AC:
1
AN:
15084
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5100
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4782
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10124
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000148
AC:
1
AN:
67690
Other (OTH)
AF:
0.000957
AC:
2
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000182
Hom.:
0
Bravo
AF:
0.000502
ESP6500AA
AF:
0.00136
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000234
AC:
28

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Apr 28, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Feb 21, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.36
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.17
T;.;.;.
Eigen
Benign
-0.039
Eigen_PC
Benign
0.043
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.83
T;T;T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.011
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;N;.;N
PhyloP100
1.9
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.9
N;.;N;N
REVEL
Benign
0.073
Sift
Uncertain
0.0030
D;.;D;D
Sift4G
Uncertain
0.018
D;D;D;D
Polyphen
0.94
P;.;.;.
Vest4
0.18
MVP
0.34
ClinPred
0.036
T
GERP RS
3.3
Varity_R
0.19
gMVP
0.082
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370788759; hg19: chr6-123869713; COSMIC: COSV100521887; API